Test Price
2,800 AED✅ Home Collection Available
SLC9A3R1 Gene Analysis for Nephrolithiasis/Osteoporosis, Hypophosphatemic Type 2 in Dubai | DNA Labs UAE
Executive Summary & Core Metrics
Clinical Excellence Guaranteed:
- Accuracy: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing (Illumina® platform, full-gene coverage).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM within Dubai and select UAE emirates.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation with DHA-licensed Consultant Medical Genetics specialist.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Corporate Oversight:
DNA Labs UAE — DHA Facility License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE
Test Overview & Methodology
This next-generation sequencing (NGS) test analyses the entire coding region of the SLC9A3R1 gene to identify pathogenic variants linked to hereditary hypophosphatemic nephrolithiasis, osteoporosis, and renal phosphate wasting. It empowers precise diagnosis, family screening, and tailored metabolic management under stringent UAE regulatory oversight.
| Feature | Our Service | Closest Alternative |
|---|---|---|
| Method | NGS (Illumina® platform), full-gene coverage including intronic boundaries | Sanger sequencing of selected exons only |
| Diagnostic Sensitivity | 99.9% for single-nucleotide variants and indels (including mosaic detection down to 5% allele frequency) | ~85% depending on target capture depth |
| Turnaround Time | 3–4 weeks from sample receipt | 6–8 weeks |
| DHA Accreditation | Facility License 1143; ISO 9001:2015 Certified | Variable; often lacking dedicated genetic laboratory licensing |
| Price (AED) | 2,800 | 3,200–4,500 |
Physician Insight & Safety Protocols
“As a DHA-licensed Consultant Medical Genetics specialist, I want you to understand that a genetic result is a tool for clarity, not a verdict. Used wisely with your nephrologist or endocrinologist, it can guide proactive bone health and kidney stone prevention. Always correlate findings with your full clinical picture and family history.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403
⚠️ Medication Advisory
Do not discontinue prescribed phosphate supplements, vitamin D analogs, or any metabolic medication without consulting your treating physician. Stopping such therapies abruptly may worsen bone density or electrolyte balance.
Exclusion Criteria & Emergency Red Flags
- Active systemic infection or fever at the time of sample collection.
- Severe bleeding disorder or current use of anticoagulants (require physician clearance and INR verification within therapeutic range).
- Known allergy to antiseptic used for venipuncture (chlorhexidine or iodine-based).
After sample collection, seek immediate medical attention if you experience:
- Excessive bleeding or swelling at the puncture site that does not subside after 10 minutes of direct pressure.
- Signs of infection (redness, warmth, purulent drainage).
- Fainting, dizziness, or severe pain persisting beyond 30 minutes.
Patient FAQ & Clinical Guidance
1. What does the SLC9A3R1 genetic test detect and why is it important?
This test detects pathogenic variants in the SLC9A3R1 gene responsible for hereditary hypophosphatemic nephrolithiasis, osteoporosis, and related phosphate-wasting disorders. Identifying the precise genetic cause enables targeted dietary management, phosphate replacement therapy, and cascade screening of at-risk family members, reducing long-term renal and skeletal complications.
2. How should I prepare for the test, and what sample is required?
Preparation involves a mandatory genetic counselling session to document family history and medication review. The test requires a simple peripheral blood draw (5 mL in EDTA tube) collected by our DHA-licensed phlebotomist at your preferred location via VIP Mobile Phlebotomy, available daily from 8 AM to 11 PM. No fasting is required.
3. How long do results take, and how are they delivered?
Results are reported within 3 to 4 weeks via a secure online portal with encrypted access. A telephonic post-test clinical guidance session with our Consultant Medical Genetics specialist is automatically scheduled to explain findings in plain language and discuss next steps for management and family planning.
4. Can I get this test if I have already received a genetic test elsewhere?
Yes. This test uses a different methodology (NGS with full-gene coverage) that may detect variants missed by older techniques. However, please provide prior test reports during genetic counselling to avoid redundant analysis and ensure comprehensive interpretation of all findings.
UAE Regulatory & Data Privacy Adherence
Legal Compliance Framework
All procedures strictly adhere to:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) — ensuring encryption, consent management, and controlled access to your genomic data.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields — governing electronic health records, telemedicine, and digital data exchange.
- Federal Decree-Law No. 4 of 2016 on Medical Liability — defining standards of care for genetic testing, pre-test counselling, and post-test disclosure.
Laboratory services are delivered under DHA Facility License 1143 (Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE) with full ISO 9001:2015 certification for quality management systems.
Clinical & Logistical Metadata
| Test Name | SLC9A3R1 Gene Analysis for Nephrolithiasis/Osteoporosis, Hypophosphatemic Type 2 |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Peripheral whole blood (EDTA tube, 5 mL) |
| Methodology Used | Next-Generation Sequencing (NGS) — Illumina® platform, full-gene coverage including exon-intron boundaries |
| ICD-10-CM Code | E83.31, N20.0 |
| LOINC Code | 81247-9 |
| DHA Facility License & Laboratory Address | DHA License No. 1143 — Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians